Significant landmark as NICE recommends AstraZeneca’s chronic kidney disease treatment Forxiga
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too badams Thu, […]
Eli Lilly nixes Verzenio’s phase 3 HER2-positive early breast cancer trial fkansteiner Thu, 02/03/2022 – 11:26
Takeda’s Sequeira to head up newly created global portfolio division, Kim to lead US unit esagonowsky Thu, 02/03/2022 […]
After disastrous start to launch, Biogen still expects ‘minimal’ sales from Aduhelm this year esagonowsky Thu, 02/03/2022 – 08:47
Cancer screening ‘not elective,’ says president’s cancer panel, as it pushes for better awareness badams Thu, 02/03/2022 – […]
The government has written off almost £10bn of spending on personal protective equipment (PPE) that was either unusable, […]
Ventilators on displayWe’ve probably reached the stage of the pandemic where someone, somewhere, must be dreaming up plans […]
Research in medicine needs someone with the power to investigate and uncover misconduct by professionals and organisations who […]
Fake dataTwo years ago, scrutiny of the individual patient data in 150 randomised controlled trials (RCTs) submitted for […]